Results 1 to 10 of about 2,359,106 (231)

Global Burden of Colistin-Resistant Bacteria: Mobilized Colistin Resistance Genes Study (1980–2018) [PDF]

Microorganisms, 2019
Colistin is considered to be an antimicrobial of last-resort for the treatment of multidrug-resistant Gram-negative bacterial infections. The recent global dissemination of mobilized colistin resistance (mcr) genes is an urgent public health threat. An accurate estimate of the global prevalence of mcr genes, their reservoirs and the potential pathways ...
Youjun Feng, Narayan Paudyal, Shao-Hua Xie   +2 more
exaly   +5 more sources

Colistin resistance in carbapenemase-producing bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis

International Journal of Antimicrobial Agents, 2018
George L Daikos, Joseph Papaparaskevas, Michael Samarkos   +2 more
exaly  

Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.

Antimicrobial Agents and Chemotherapy, 2019
Chunquan Xu, Tieli Zhou
exaly  

Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

Pharmacotherapy, 2010
Juergen Bulitta, Brian T Tsuji, Neang S. Ly   +2 more
exaly  

Phage-mediated colistin resistance in

Drug Resistance Updates
Francesco Imperi, Giordano Rampioni, Livia Leoni   +2 more
exaly  

Plasmid-mediated colistin-resistance genes: mcr

Trends in Microbiology
Jian-Hua Liu, Jianzhong Shen, Timothy R. Walsh   +2 more
exaly  

Colistin Resistance and Management of Drug Resistant Infections

Canadian Journal of Infectious Diseases and Medical Microbiology, 2022
Colistin resistance is a globalized sensible issue because it has been considered a drug of the last-line resort to treat drug-resistant bacterial infections.
Juhi Sharma, Divakar Sharma, Amit Singh, Kumari Sunita   +3 more
doaj   +4 more sources

Old drug, new findings: colistin resistance and dependence of [PDF]

Precision and Future Medicine, 2017
Colistin is an old drug, and its use has recently resurged because of increasing antibiotic resistance in gram-negative bacteria such as Acinetobacter baumannii.
Kwan Soo Ko, Yujin Choi, Ji-Young Lee
doaj   +3 more sources

Transposon insertion sequencing of Pseudomonas aeruginosa identifies multiple intersecting pathways essential for extreme colistin resistance. [PDF]

PLoS Pathogens
Colistin is used to treat antibiotic resistant gram-negative infections, including those caused by Pseudomonas aeruginosa (Pa). Using a diverse collection of clinical isolates, we identified BWH047, a colistin-resistant isolate with an extremely high ...
Madeleine B Vessely, Ryan P Kich, Samuel W M Gatesy, Hanna K Bertucci, Aliki Valdes, Clara Luczak, Shradha Rao, Artur Muszyński, Parastoo Azadi, Casey N Kellogg, Brandon L Jutras, John Mekalanos, Alan R Hauser, Egon A Ozer, Kelly E R Bachta   +14 more
doaj   +2 more sources

An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review [PDF]

Veterinary World, 2019
Colistin, also known as polymyxin E, is an antimicrobial agent that is effective against a variety of Gram-negative bacilli, especially the Enterobacteriaceae family. Recently, the wide dissemination of colistin-resistance has brought strong attention to
Shoroq Q. Shatnawi, Mohammad H. Gharaibeh   +1 more
core   +5 more sources